Cinnamide chemokine CCR3 antagonists

Author：  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.12, Iss.11, 2002-11, pp. : 1741-1745

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemokine CCR3 antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 9, 2000-09 ,pp. : 1455-1459

Informa Healthcare

Access to resources Recommend Favorite

Chemokine CCR3 antagonists

By Naya Akira   Saeki Toshihiko  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 1, 2004-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

Recent progress in the development of antagonists to the chemokine receptors CCR3 and CCR4

By Pease James Edward   Horuk Richard  

Expert Opinion on Drug Discovery, Vol. 9, Iss. 5, 2014-05 ,pp. : 467-483

Informa Healthcare

Access to resources Recommend Favorite

GlaxoSmithKline’s CCR3 chemokine receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 4, 2004-04 ,pp. : 577-582

Informa Healthcare

Access to resources Recommend Favorite

Novel chemokine CCR1 receptor antagonists

By  

Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 8, 2001-08 ,pp. : 1355-1357

Informa Healthcare

Access to resources Recommend Favorite